Zdrowie i gospodarka · 28/01/1994

FDA Amends Final Monograph for OTC Antihistamine Drug Products to Include Doxylamine Succinate

The US Food and Drug Administration (FDA) is amending the final monograph for over-the-counter (OTC) antihistamine drug products to include the ingredient doxylamine succinate, following recommendations from its Nonprescription Drugs Advisory Committee (NDAC). This decision is part of the FDA's ongoing review of OTC drug products.